Last reviewed · How we verify
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
The aim of this study is to assess performance of using healthcare tools to understand genital Herpes Simplex Virus-2 (HSV-2) in patients ≥ 18 years of age in the United States and Europe. More specifically, the study aims to evaluate patient-reported outcome and quality-of-life endpoints as well as the performance study procedures in a decentralised setting. Ultimately, this study will allow generating additional real-world evidence (RWE) on patterns of recurrences and other key parameters.
Details
| Lead sponsor | GlaxoSmithKline |
|---|---|
| Status | COMPLETED |
| Enrolment | 537 |
| Start date | Wed Jun 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Mar 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Herpes Genitalis
Interventions
- Blood sampling
- Anogenital lesion swab collection
Countries
France, Italy, Finland, United Kingdom, United States, Spain